Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

463 trials with published results (33%)

Research Maturity

1115 completed trials (80% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

3.1%

43 terminated out of 1387 trials

Success Rate

96.3%

+9.7% vs benchmark

Late-Stage Pipeline

36%

499 trials in Phase 3/4

Results Transparency

42%

463 of 1115 completed with results

Key Signals

463 with results96% success43 terminated

Data Visualizations

Phase Distribution

1,213Total
Not Applicable (177)
P 1 (261)
P 2 (276)
P 3 (265)
P 4 (234)

Trial Status

Completed1,115
Unknown80
Recruiting54
Terminated43
Withdrawn35
Active Not Recruiting33

Trial Success Rate

96.3%

Benchmark: 86.6%

Based on 1115 completed trials

Clinical Trials (1387)

Showing 20 of 20 trials
NCT07215858Phase 2RecruitingPrimary

BPL-1357 Against H1N1 Influenza Virus Challenge

NCT07149428Enrolling By Invitation

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT07110532Phase 1RecruitingPrimary

pH1N1 Blinded Challenge Study

NCT07854392Phase 4RecruitingPrimary

A Phase IV Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults

NCT04613206Phase 2Active Not Recruiting

High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients

NCT06560151Phase 2CompletedPrimary

Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59

NCT06160128Recruiting

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

NCT07846423Not ApplicableRecruitingPrimary

Abbott ID NOW Point-of-Care Testing

NCT06076421Not ApplicableCompleted

Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol

NCT07508189Not ApplicableCompletedPrimary

Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho

NCT04164212Phase 4CompletedPrimary

Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection

NCT07703514Phase 1Not Yet RecruitingPrimary

Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates

NCT06094010Phase 3RecruitingPrimary

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

NCT05947071Phase 2Recruiting

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

NCT07739446Not ApplicableEnrolling By Invitation

Effect of Surgical Masks in Preventing Acute Respiratory Infections

NCT07737106Phase 1CompletedPrimary

Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)

NCT07040202Recruiting

Immune Responses to Dengue and Sepsis

NCT01386424Recruiting

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

NCT07340047Phase 1WithdrawnPrimary

H1ssF Flu Vaccine Clinical Trial

NCT07832201Phase 4Not Yet RecruitingPrimary

A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)

Scroll to load more

Research Network

Activity Timeline